Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example

Molecular characterization is increasingly changing clinical practice, in both diagnosis and treatment. BRAF is a proto-oncogene that is mutated in ~2%–4% of lung cancers, but the incidence rises to 40%–45% among papillary thyroid cancers. Furthermore, BRAF is a promising target in lung cancer treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerratana, Lorenzo, De Maglio, Giovanna, De Pellegrin, Alessandro, Follador, Alessandro, Rihawi, Karim, Pizzolitto, Stefano, Puglisi, Fabio, Fasola, Gianpiero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012847/
https://www.ncbi.nlm.nih.gov/pubmed/27621653
http://dx.doi.org/10.2147/OTT.S104748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012847/
https://www.ncbi.nlm.nih.gov/pubmed/27621653
http://dx.doi.org/10.2147/OTT.S104748

Ejemplares similares